{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:46:15Z","timestamp":1788072375535,"version":"build-2784847793"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T00:00:00Z","timestamp":1491782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00586-017-5086-7","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T09:55:43Z","timestamp":1491818143000},"page":"236-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy"],"prefix":"10.1007","volume":"26","author":[{"given":"Noritaka","family":"Yonezawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,10]]},"reference":[{"key":"5086_CR1","doi-asserted-by":"publisher","first-page":"410973","DOI":"10.1155\/2012\/410973","volume":"2012","author":"M Balke","year":"2012","unstructured":"Balke M, Henrichs MP, Gosheger G, Ahrens H, Streitbuerger A, Koehler M, Bullmann V, Hardes J (2012) Giant cell tumors of the axial skeleton. Sarcoma 2012:410973. doi:\n                        10.1155\/2012\/410973","journal-title":"Sarcoma"},{"issue":"2","key":"5086_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1309\/BPET-F2PE-P2BD-J3P3","volume":"117","author":"S Roux","year":"2002","unstructured":"Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X (2002) RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol 117(2):210\u2013216. doi:\n                        10.1309\/BPET-F2PE-P2BD-J3P3","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"5086_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","volume":"11","author":"D Thomas","year":"2010","unstructured":"Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11(3):275\u2013280. doi:\n                        10.1016\/S1470-2045(10)70010-3","journal-title":"Lancet Oncol"},{"issue":"9","key":"5086_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","volume":"14","author":"S Chawla","year":"2013","unstructured":"Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, Schuetze S, Skubitz K, Staddon A, Thomas D, Qian Y, Jacobs I (2013) Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol 14(9):901\u2013908. doi:\n                        10.1016\/S1470-2045(13)70277-8","journal-title":"Lancet Oncol"},{"issue":"16","key":"5086_CR5","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","volume":"18","author":"DG Branstetter","year":"2012","unstructured":"Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I (2012) Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 18(16):4415\u20134424. doi:\n                        10.1158\/1078-0432.CCR-12-0578","journal-title":"Clin Cancer Res"},{"issue":"9","key":"5086_CR6","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1245\/s10434-015-4634-9","volume":"22","author":"P Rutkowski","year":"2015","unstructured":"Rutkowski P, Ferrari S, Grimer RJ, Stalley PD, Dijkstra SP, Pienkowski A, Vaz G, Wunder JS, Seeger LL, Feng A, Roberts ZJ, Bach BA (2015) Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone. Ann Surg Oncol 22(9):2860\u20132868. doi:\n                        10.1245\/s10434-015-4634-9","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"5086_CR7","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.spinee.2014.02.019","volume":"14","author":"TA Mattei","year":"2014","unstructured":"Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E (2014) Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab. Spine J 14(7):e15\u2013e21. doi:\n                        10.1016\/j.spinee.2014.02.019","journal-title":"Spine J"},{"issue":"5","key":"5086_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4184\/asj.2016.10.5.945","volume":"10","author":"SS Randhawa","year":"2016","unstructured":"Randhawa SS, Kwan AK, Chiu CK, Chan CY, Kwan MK (2016) Neurological recovery in two patients with cauda equina syndrome secondary to L5 lumbar spine giant cell tumour after treatment with denosumab without surgery. Asian Spine J 10(5):945\u2013949. doi:\n                        10.4184\/asj.2016.10.5.945","journal-title":"Asian Spine J"},{"issue":"3","key":"5086_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4184\/asj.2016.10.3.553","volume":"10","author":"D Kajiwara","year":"2016","unstructured":"Kajiwara D, Kamoda H, Yonemoto T, Iwata S, Ishii T, Tsukanishi T, Ohtori S, Yamazaki M, Okawa A (2016) Denosumab for treatment of a recurrent cervical giant-cell tumor. Asian Spine J 10(3):553\u2013557. doi:\n                        10.4184\/asj.2016.10.3.553","journal-title":"Asian Spine J"},{"key":"5086_CR10","doi-asserted-by":"publisher","first-page":"496351","DOI":"10.1155\/2013\/496351","volume":"2013","author":"A Agarwal","year":"2013","unstructured":"Agarwal A, Larsen BT, Buadu LD, Dunn J, Crawford R, Daniel J, Bishop MC (2013) Denosumab chemotherapy for recurrent giant-cell tumor of bone: a case report of neoadjuvant use enabling complete surgical resection. Case Rep Oncol Med 2013:496351. doi:\n                        10.1155\/2013\/496351","journal-title":"Case Rep Oncol Med"},{"key":"5086_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000001951","author":"R Kumar","year":"2016","unstructured":"Kumar R, Meis JM, Amini B, McEnery KW, Madewell JE, Rhines LD, Benjamin RS (2016) Giant cell tumor of cervical spine presenting as acute asphyxia: successful surgical resection after down-staging with denosumab. Spine (Phila Pa 1976). doi:\n                        10.1097\/BRS.0000000000001951","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"5086_CR12","doi-asserted-by":"publisher","first-page":"E178","DOI":"10.1097\/BRS.0000000000001191","volume":"41","author":"RA Carvalho Cavalcante de","year":"2016","unstructured":"de Carvalho Cavalcante RA, Silva Marques RA, dos Santos VG, Sabino E, Fraga AC Jr, Zaccariotti VA, Arruda JB, Fernandes YB (2016) Spondylectomy for giant cell tumor after denosumab therapy. Spine (Phila Pa 1976) 41(3):E178\u2013E182. doi:\n                        10.1097\/BRS.0000000000001191","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"5086_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3171\/2014.10.SPINE13937","volume":"22","author":"T Goldschlager","year":"2015","unstructured":"Goldschlager T, Dea N, Boyd M, Reynolds J, Patel S, Rhines LD, Mendel E, Pacheco M, Ramos E, Mattei TA, Fisher CG (2015) Giant cell tumors of the spine: has denosumab changed the treatment paradigm? J Neurosurg Spine 22(5):526\u2013533. doi:\n                        10.3171\/2014.10.SPINE13937","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"5086_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/03008207.2013.848202","volume":"54","author":"CP Lau","year":"2013","unstructured":"Lau CP, Huang L, Wong KC, Kumta SM (2013) Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. Connect Tissue Res 54(6):439\u2013449. doi:\n                        10.3109\/03008207.2013.848202","journal-title":"Connect Tissue Res"},{"issue":"5","key":"5086_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1634\/theoncologist.2013-0432","volume":"19","author":"L Heijden van der","year":"2014","unstructured":"van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovee JV, Hogendoorn PC, Gelderblom H (2014) The clinical approach toward giant cell tumor of bone. Oncologist 19(5):550\u2013561. doi:\n                        10.1634\/theoncologist.2013-0432","journal-title":"Oncologist"},{"issue":"12","key":"5086_CR16","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1302\/0301-620X.93B12.27663","volume":"93","author":"CL Gaston","year":"2011","unstructured":"Gaston CL, Bhumbra R, Watanuki M, Abudu AT, Carter SR, Jeys LM, Tillman RM, Grimer RJ (2011) Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Jt Surg Br 93(12):1665\u20131669. doi:\n                        10.1302\/0301-620X.93B12.27663","journal-title":"J Bone Jt Surg Br"},{"issue":"10","key":"5086_CR17","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1302\/0301-620X.92B10.23495","volume":"92","author":"Y Gortzak","year":"2010","unstructured":"Gortzak Y, Kandel R, Deheshi B, Werier J, Turcotte RE, Ferguson PC, Wunder JS (2010) The efficacy of chemical adjuvants on giant-cell tumour of bone. An in vitro study. J Bone Jt Surg Br 92(10):1475\u20131479","journal-title":"J Bone Jt Surg Br"},{"issue":"1","key":"5086_CR18","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1097\/BRS.0b013e3182233ccd","volume":"37","author":"S Boriani","year":"2012","unstructured":"Boriani S, Bandiera S, Casadei R, Boriani L, Donthineni R, Gasbarrini A, Pignotti E, Biagini R, Schwab JH (2012) Giant cell tumor of the mobile spine: a review of 49 cases. Spine (Phila Pa 1976) 37(1):E37\u2013E45. doi:\n                        10.1097\/BRS.0b013e3182233ccd","journal-title":"Spine (Phila Pa 1976)"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00586-017-5086-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-017-5086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-017-5086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T23:50:51Z","timestamp":1496361051000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00586-017-5086-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,10]]},"references-count":18,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["5086"],"URL":"https:\/\/doi.org\/10.1007\/s00586-017-5086-7","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,10]]}}}